Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: A Case-Control Study

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Bérard, Annie M ^a,b   Bedel, Aurélie ^a,b   Le Trequesser, Rémi ^c   Freyburger, Geneviève ^a   Nurden, Alan ^a   Colomer, Sylvie ^a   Guérin, Viviane ^a   Vergnes, Marie Christine ^a   Becker, François ^d   Camelot, Gabriel ^d   Bressolette, Luc ^e   Lacroix, Philippe ^f   Cambou, Jean Pierre ^g   Bura Rivière, Alessandra ^g   Emmerich, Joseph ^h   Darmon, Michel ^a,b   Deletraz, Anne Marie ^a,b   Mesli, Samir ^a,b   Colombies, Brigitte ^a   Vanbrugghe, Virginie ^a   Conri, Claude ^a   Constans, Joël ^a,b   more..

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Usines FORD ^*  (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e BREST UNIVERSITY HOSPITAL   (France)

^f LIMOGES UNIVERSITY HOSPITAL   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; APOLIPOPROTEIN A1; BLOOD CLOTTING FACTOR 5 LEIDEN; COPPER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PYRIDOXAL 5 PHOSPHATE; ZINC;

ADULT; ARTICLE; BUERGER DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; COPPER BLOOD LEVEL; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PREVALENCE; RISK ASSESSMENT; SMOKING;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; THROMBOANGIITIS OBLITERANS; YOUNG ADULT;

EID: 84875331513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037882     Document Type: Article

References (36)

1. Daskalopoulou SS, Pathmarajah M, Kakkos SK, Daskalopoulos ME, Holloway P, et al. (2008) Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 72: 441-448.
2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al. (1992) Mortality over a period of 10 years in patients with peripheral vascular disease. N Engl J Med 326: 381-386.
3. Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, et al. (2005) Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation 112: 2703-2707.
4. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, et al. (2003) Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163: 884-892.
5. Lane JS, Vittinghoff E, Lane KT, Hiramoto JS, Messina LM, (2006) Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. J Vasc Surg 44: 319-324.
6. Valentine RJ, Kaplan HS, Green R, Jacobsen DW, Myers SI, et al. (1996) Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg 23: 53-61.
7. O'Hare AM, Glidden DV, Fox CS, Hsu CY, (2004) High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000. Circulation 109: 320-323.
8. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF 3rd, et al (1984) Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199: 223-233.
9. Valentine RJ, Guerra R, Stephan P, Scoggins E, Clagett GP, et al. (2004) Family history is a major determinant of subclinical peripheral arterial disease in young adults. J Vasc Surg 39: 351-356.
10. Małecki R, Zdrojowy K, Adamiec R, (2009) Thromboangiitis obliterans in the 21st century-A new face of disease. Atherosclerosis 206: 328-334.
11. Avcu F, Akar E, Demirkilic U, Yilmaz E, Akar N, et al. (2000) The role of prothrombotic mutations in patients with Buerger's disease. Thromb Res 100: 143-147.
12. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, et al. (1996) Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 94: 11-15.
13. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, et al. (2000) Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101: E16-22.
14. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, et al. (2003) ESH/ESC hypertension guidelines committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 21: 1779-1786.
15. Bérard AM, Dabadie H, Palos-Pinto A, Dumon MF, Darmon M, (2004) Reduction of dietary saturated fatty acids correlates with increased plasma lecithin cholesterol acyltransferase activity in humans. Eur J Clin Nutr 58: 881-887.
16. Constans J, Guérin V, Couchouron A, Seigneur M, Ryman A, et al. (1998) Autoantibodies directed against phospholipids or human beta 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest 28: 115-122.
17. Newcombe RG, (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Statistics in Medicine 17: 857-872.
18. Armitage P, Berry G (1994) Statistical Methods in Medical Research (3rd ed.). London: Blackwell, p131.
19. Craig WY, Palomaki GE, Haddow J, (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 298: 784-788.
20. Giraud DW, Martin HD, Driskell JA, (1995) Erythrocyte and plasma B-6 vitamin concentrations of long-term tobacco smokers, chewers, and nonusers. Am J Clin Nutr 62: 104-109.
21. Barua RS, Sy F, Srikanth S, Huang G, Javed U, et al. (2010) Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol 30: 75-79.
22. Zeiher AM, Schachinger V, Minners J, (1995) Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92: 1094-1100.
23. Kelly PJ, Kistler JP, Shih VE, Mandell R, Atassi N, et al. (2004) Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke 35: 12-15.
24. Cheng CH, Lin PT, Liaw YP, Ho CC, Tsai TP, et al. (2008) Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease. Nutrition 24: 239-244.
25. Ghayour-Mobarhan M, Taylor A, Kazemi-Bajestani SM, Lanham-New S, Lamb DJ, et al. (2008) Serum zinc and copper status in dyslipidaemic patients with and without established coronary artery disease. Clin Lab 54: 321-329.
26. Dieplinger B, Lingenhel A, Baumgartner N, Poelz W, Dieplinger H, et al. (2007) Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Clin Chem 53: 1298-1305.
27. Palabrica TM, Liu AC, Aronovitz MJ, Furie B, Lawn RM, et al. (1995) Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat Med 1: 256-259.
28. Zintzaras E, Zdoukopoulos N, (2009) A field synopsis and meta-analysis of genetic association studies in peripheral arterial disease: The CUMAGAS-PAD database. Am J Epidemiol 170: 1-11.
29. Kritzik M, Savage B, Nugent DJ, Santoso S, Ruggeri ZM, et al. (1998) Nucleotide polymorphisms in the alpha2 gene define multiple alleles that are associated with differences in platelet alpha2 beta1 density. Blood 92: 2382-2388.
30. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J, (2003) Platelet activation is increased in peripheral arterial disease. J Vasc Surg 38: 99-103.
31. Rajagopalan S, Mckay I, Ford I, Bachoo P, Greaves M, et al. (2007) Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management. J Vasc Surg 46: 485-490.
32. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR, (2009) Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease. A meta-analysis of randomized trials. JAMA 301: 1909-1919.
33. Peyrot I, Garsaud AM, Saint-Cyr I, Quitman O, Sanchez B, et al. (2007) Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol 21: 388-391.
34. Piazza G, Creager MA, (2010) Thromboangiitis obliterans. Circulation 121: 1858-1861.
35. Wang CT, (1996) Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages. Eur J Clin Chem Clin Biochem 34: 493-497.
36. Bona E, Marsano F, Cavaletto M, Berta G, (2007) Proteomic characterization of copper stress response in Cannabis sativa roots. Proteomics 7: 1121-1130.